Advertisement

Familial Mediterranean Fever

  • Murat İnançEmail author
  • Can Baykal
Chapter

Abstract

Familial Mediterranean fever (FMF) is the most common hereditary recurrent fever syndrome that may cause serositis, synovitis, and/or cutaneous inflammation. FMF belongs to the group of autoinflammatory diseases with mutations in MEFV gene that encodes pyrin, which usually affects people from Mediterranean origin like Sephardic Jews, Turks, Arabs, and Armenians. The clinical picture of FMF consists of attacks with rapid development of high-grade fever and constitutional symptoms accompanied by acute-phase response. Duration of attacks is generally short (6–96 h) with irregular occurrences. The main clinical features during attacks are peritonitis (95 %), arthritis (>50 %) (mono-oligoarticular), pleuritis (40 %), and less frequently pericarditis, scrotal swelling, myalgia, and erysipeloid skin rash. The first attack appears before the age of 20 in more than 85 % of the patients. The most important chronic manifestation of FMF is secondary AA amyloidosis which generally presents with proteinuria and may cause chronic renal insufficiency. Erysipeloid erythema (ELE) is the typical skin rash of FMF. The reported frequency of ELE is variable (3–46 %) and it is prevalent in childhood-onset patients. ELE may be an early sign and sometimes precedes systemic symptoms. Bullous lesions, erythema, urticaria, and pyoderma have been reported as additional skin manifestations in patients with FMF. Other diseases with skin manifestations may accompany FMF (or patients with MEVF mutations) like polyarteritis nodosa, Henoch-Schonlein purpura, Behçet’s disease, and relapsing polychondritis. Differential diagnosis is needed as erythematous patches resembling FMF lesions may be caused by other dermatoses like erysipelas, cellulitis, and Sweet’s syndrome. Other hereditary recurrent fever syndromes, for example, HIDS (hyperimmunoglobulinemia D syndrome) and TRAPS, with various skin manifestations are included in the differential diagnosis of FMF. It should be noted that the histopathological features of ELE and nonspecific skin lesions are not diagnostic for FMF.

Keywords

Familial Mediterranean Fever Polyarteritis Nodosa Skin Manifestation Autosomal Recessive Disease Relapse Polychondritis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Grateu G. Clinical and genetic aspects of the hereditary periodic fever syndromes. Rheumatology. 2004;43:410–5.CrossRefGoogle Scholar
  2. 2.
    Kastner D, Aksentijevich I, Goldbach-Mansky R. Autoinflammatory disease reloaded: a clinical perspective. Cell. 2010;140:784–90.PubMedCrossRefGoogle Scholar
  3. 3.
    Livneh A, Langevitz P. Diagnostic and treatment concerns in familial Mediterranean fever. Baillieres Clin Rheumatol. 2000;14:477–98.Google Scholar
  4. 4.
    Turkish FMF Sudy Group. Familial mediterranean fever in Turkey: results of a nationwide multicenter study. Medicine. 2005;84:1–11.CrossRefGoogle Scholar
  5. 5.
    Sayarlıoğlu M, Çefle A, İnanç M, et al. Characteristics of patients with adult onset familial Mediterranean fever in Turkey: analysis of 401 cases. Int J Clin Pract. 2005;59:202–5.PubMedGoogle Scholar
  6. 6.
    Barzilai A, et al. Erysipelas-like erythema of familial Mediterranean fever: clinicopathologic correlation. J Am Acad Dermatol. 2000;42:791–5.PubMedCrossRefGoogle Scholar
  7. 7.
    Akman A, et al. Recurrent bullous lesions associated with familial Mediterranean fever: a case report. Clin Exp Dermatol. 2008;34:216–8.CrossRefGoogle Scholar
  8. 8.
    Salihoğlu A, Seyahi E, Çelik S, Yurdakul S. Relapsing polychondritis in a patient with familial Mediterranean fever and amyloidosis. Clin Exp Rheumatol. 2008;26 Suppl 50:S-125.Google Scholar
  9. 9.
    Ben-Chetrit E, Peleg H, Aamar S, Heyman SN. The spectrum of MEVF clinical presentations – is it familial mediterranean fever only? Rheumatology. 2009;48:1455–9.PubMedCrossRefGoogle Scholar
  10. 10.
    Cohen PR, Kurzrock R. Sweet’s syndrome revisited: a review of disease concepts. Int J Dermatol. 2003;42:761–78.PubMedCrossRefGoogle Scholar
  11. 11.
    Kanazawa N, Furukawa F. Autoinflammatory syndromes with a dermatological perspective. J Dermatol. 2007;34:601–18.PubMedCrossRefGoogle Scholar
  12. 12.
    Livneh A, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum. 1997;40:1879–85.PubMedCrossRefGoogle Scholar
  13. 13.
    Federici L, et al. A decision tree for genetic diagnosis of hereditary periodic fever in unselected patients. Ann Rheum Dis. 2006;65:1427–32.PubMedCrossRefGoogle Scholar
  14. 14.
    Yalçınkaya F, et al. A new criteria for the diagnosis of familial mediterranean fever in childhood. Rheumatology. 2009;48:395–8.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2014

Authors and Affiliations

  1. 1.Department of Internal Medicine, Division of Rheumatology, Istanbul Faculty of MedicineIstanbul UniversityIstanbulTurkey
  2. 2.Department of DermatologyIstanbul University, Istanbul Medical FacultyIstanbulTurkey

Personalised recommendations